Skip to main content

Arthur Tzianabos

Equibles does not estimate personal net worth.

Get an email with a short summary when Q32 Bio Inc. publishes a filing, an earnings call transcript or a press release.

Get QTTB alerts

About Arthur Tzianabos

Arthur Tzianabos is recorded as Board Member at Q32 Bio Inc. (QTTB) since January 1, 2016. The newest filing on record that lists Arthur Tzianabos as Board Member at Q32 Bio Inc. (QTTB) is dated April 30, 2026. Q32 Bio Inc. reported in an 8-K filed March 27, 2024 that Arthur Tzianabos was appointed Class II director, effective March 25, 2024. The proxy statement of Q32 Bio Inc. reports total compensation of $1,672,061 for Arthur Tzianabos in fiscal 2022, including a base salary of $437,151. Disclosed compensation is on record for 5 fiscal years. Q32 Bio Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Q32 Bio Inc. includes Albert Seymour, Ph.D. (CEO and Board Member), Jodie Morrison (CEO and Board Member), Paul G. Alloway, Ph.D. (CEO and COO) and 7 others.

“Dr. Tzianabos, Ms. Morrison and Ms. LaPorte were appointed as Class II directors (terms expire at our 2026 annual meeting)”
Q32 Bio Inc. Form 8-K, filed March 27, 2024 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2016-01-01–present

Leadership on record at Q32 Bio Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Q32 Bio Inc. (QTTB) $437,151 $1,672,061
2021 Q32 Bio Inc. (QTTB) $583,100 $3,607,339
2020 Q32 Bio Inc. (QTTB) $563,200 $885,960
2019 Q32 Bio Inc. (QTTB) $537,600 $5,062,877
2018 Q32 Bio Inc. (QTTB) $490,500 $4,313,115

Recent activity